Pharmaceutical industry and healthcare
Pharmaceutical industry and healthcare is a research topic within Pharmacology. Science Explorer counts 15k research works in it since 1950. 18.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the impact of pharmaceutical industry sponsorship on research outcome and quality, including conflicts of interest, financial ties between physicians and industry, direct-to-consumer advertising, publication bias, and ethical considerations in medical practice. The papers investigate the influence of funding sources on clinical trials, prescribing behavior, and the integrity of medical science.
- Pharmaceutical Industry
- Conflict of Interest
- Research Outcome
- Financial Sponsorship
- Physician Relationships
- Direct-to-Consumer Advertising
- Clinical Trials
- Publication Bias
- Medical Ethics
- Prescribing Behavior
- Research works
- 15k fractional, since 1950
- In the world top 10%
- 2.7k per year above
- Top-10% rate
- 18.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -1% the tick is no change
Which countries lead Pharmaceutical industry and healthcare research?
By volume, the United States and the United Kingdom publish the most (839 and 140 works in 2022–2025).
By volume, 2022–2025
- 1 United States 839 works
- 2 United Kingdom 140 works
- 3 India 90 works
- 4 Canada 81 works
- 5 Australia 73 works
- 6 Germany 46 works
- 7 France 44 works
- 8 Japan 43 works
- 9 China 40 works
- 10 Brazil 40 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Pharmaceutical industry and healthcare research?
By volume in 2022–2025, BMJ Group (United Kingdom) publishes the most Pharmaceutical industry and healthcare research, followed by Harvard University and Yale University.
By volume, 2022–2025
- 1 BMJ Group (United Kingdom)?? 18 works
- 2 Harvard UniversityUnited States 17 works
- 3 Yale UniversityUnited States 16 works
- 4 Johns Hopkins UniversityUnited States 14 works
- 5 Brigham and Women's HospitalUnited States 13 works
- 6 University of North Carolina at Chapel HillUnited States 13 works
- 7 University of California, San FranciscoUnited States 11 works
- 8 University of TorontoCanada 11 works
- 9 The University of SydneyAustralia 10 works
- 10 University of MichiganUnited States 10 works
Who are the leading researchers in Pharmaceutical industry and healthcare?
The most-cited researchers publishing on Pharmaceutical industry and healthcare include David Moher, Asbjørn Hróbjartsson and Martin McKee.
- 1 David Moher Canada 38k citations
- 2 Asbjørn Hróbjartsson Denmark 13k citations
- 3 Martin McKee United Kingdom 5.4k citations
- 4 Harlan M. Krumholz United States 4.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Pharmaceutical industry and healthcare research done?
The largest centres of Pharmaceutical industry and healthcare research in 2022–2025 are New York (United States), Boston (United States), London (United Kingdom) and Baltimore (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Boston, Baltimore and Philadelphia.
Largest cities, 2022–2025
- 1 New York United States 47 works
- 2 Boston United States 41 works
- 3 London United Kingdom 40 works
- 4 Baltimore United States 27 works
- 5 Washington D.C. United States 27 works
- 6 Philadelphia United States 27 works
- 7 Toronto Canada 26 works
- 8 Cambridge United States 23 works
- 9 Sydney Australia 23 works
- 10 New Haven United States 20 works
Where it is the local speciality
- BostonUS · 41.1 works6.1×
- BaltimoreUS · 27.2 works6.1×
- PhiladelphiaUS · 26.7 works5.5×
Location quotient: how much more of its research is in Pharmaceutical industry and healthcare than the world average.
Where is the best place to study Pharmaceutical industry and healthcare?
Among universities, judged by research, Harvard University, Yale University and Johns Hopkins University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Harvard UniversityUnited States | 73.9 | 38.6% | 7.5× | 17 | -9.6% |
| 2 | Yale UniversityUnited States | 61.6 | 20.4% | 8.8× | 16 | +39.8% |
| 3 | Johns Hopkins UniversityUnited States | 52.7 | 22.6% | 6.9× | 14 | +46.2% |
| 4 | University of California, San FranciscoUnited States | 50.3 | 17.9% | 9.7× | 11 | -15.9% |
| 5 | The University of SydneyAustralia | 44.8 | 25.0% | 5.7× | 10 | +44.5% |
| 6 | University of PennsylvaniaUnited States | 32.1 | 21.4% | 5.5× | 9 | +12.6% |
| 7 | Stanford UniversityUnited States | 30.7 | 19.1% | 4.0× | 9 | +96.6% |
| 8 | University of TorontoCanada | 29.2 | 17.9% | 4.0× | 11 | -6.4% |
| 9 | University of North Carolina at Chapel HillUnited States | 23.9 | 4.0% | 4.1× | 13 | +111.8% |
| 10 | University of MichiganUnited States | 18.3 | 13.3% | 3.9× | 10 | -4.8% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Pharmaceutical industry and healthcare research growing?
Output in 2018–2022 was 1% lower than in 2013–2017, peaking in 2020. The fastest-growing topics are Pharmaceutical industry and healthcare.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.